Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● From a short-term investment perspective, the company presents a deteriorated fundamental situation


Strengths

● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 73% by 2024.

● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The opinion of analysts covering the stock has improved over the past four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The firm trades with high earnings multiples: 33.35 times its 2022 earnings per share.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.